Living with MS – A patient’s story


Diagnosed with MS almost two decades ago, Marc Vaillancourt refused to change his lifestyle

Developing the first effective drug for progressive MS

In Focus

A clinician/scientist at The Neuro played a major role in developing a drug that offers hope to people with two forms of multiple sclerosis (MS), including one where no other effective drug existed. 

Breakthrough in MS treatment


In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

$6.1 million for MNI-led multiple sclerosis study

Other News

A project led by Dr. Douglas Arnold, a researcher at the MNI, has been awarded $6.1 million to study progressive multiple sclerosis.

Gaming camera could aid MS treatment

Extra! Extra!

A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.

Obesity linked to increased risk of multiple sclerosis

Extra! Extra!

New research suggests the presence of a causal association between body mass index and risk of developing multiple sclerosis, according to a study conducted by Dr. Brent Richards and colleagues of the Lady Davis Institute at the Jewish General Hospital. This confirms previous observational studies that had suggested the existence of such a link.

New hope for treatment of multiple sclerosis


A new study led by researchers at the Montreal Neurological Institute and Hospital of McGill University and the MUHC, gets closer to identifying the mechanisms responsible for multiple sclerosis and makes headway in the search for better treatments.

Vitamin D deficiency linked to MS risk


Low levels of vitamin D significantly increase the risk of developing multiple sclerosis (MS), according to a study led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General Hospital, and published in PLOS Medicine.

World first: Launch of Quebec registry for users of medical cannabis

Other News

The Research Institute of the McGill University Health Centre and the Canadian Consortium for the Investigation of Cannabinoids have launched a registry for users of medical cannabis in Quebec that will allow physicians to better manage its use and monitor patient safety. This innovative project represents the world’s first research database on the use of cannabis for medical purposes and places the province at the forefront of research in the field of medical cannabis.